Splicing modulator FR901464 is a potential agent for colorectal cancer in combination therapy

FR901464 (FR) was first described as an anticancer drug and later identified as a modulator of splicing factor 3B subunit 1 (SF3B1). Although the effectiveness of splicing modulators has been investigated in colorectal cancer (CRC) cells, their usefulness in animal experiments has not been confirmed...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamano, Tomoki, Kubo, Shuji, Yano, Aya, Kominato, Tomoko, Tanaka, Shino, Ikeda, Masataka, Tomita, Naohiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6349454/
https://www.ncbi.nlm.nih.gov/pubmed/30719229
http://dx.doi.org/10.18632/oncotarget.26564

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6349454/
https://www.ncbi.nlm.nih.gov/pubmed/30719229
http://dx.doi.org/10.18632/oncotarget.26564

Ejemplares similares